These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4964448)

  • 21. Utility of pyruvate medium for isolation of M. bovis and M. tuberculosis resistant to INH.
    Naganathan N; Rajalakshmi R
    Indian J Med Res; 1977 Oct; 66(4):556-61. PubMed ID: 415971
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitrite impacts the survival of Mycobacterium tuberculosis in response to isoniazid and hydrogen peroxide.
    Cunningham-Bussel A; Bange FC; Nathan CF
    Microbiologyopen; 2013 Dec; 2(6):901-11. PubMed ID: 24019302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoniazid-resistant mutants of Mycobacterium tuberculosis H37RV: uptake of isoniazid and the properties of NADase inhibitor.
    Sriprakash KS; Ramakrishnan T
    J Gen Microbiol; 1970 Jan; 60(1):125-32. PubMed ID: 4992269
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth and nutrition of extremely halophilic bacteria.
    Gochnauer MB; Kushner DJ
    Can J Microbiol; 1969 Oct; 15(10):1157-65. PubMed ID: 5370997
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycobacterium tuberculosis strains showing positive iron uptake.
    Szabó I; Bory E
    Acta Microbiol Acad Sci Hung; 1973; 20(3):205-7. PubMed ID: 4205981
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 28. [Significance of homogenizing factors and of media in the isolation od INH-resistant tubercle bacilli].
    Zduńcyk-Pawelek H; Antosiewicz-Roszkiwska A; Blitek-Golc D
    Gruzlica; 1975 May; 43(5):433-40. PubMed ID: 806488
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biological properties of drug-sensitive Mycobacterium tuberculosis].
    Ginzburg TS; Klimenko MT; Sokalo SV
    Probl Tuberk; 1986; (7):58-60. PubMed ID: 3094003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary drug resistance: a continuing survey of tubercle bacilli in a veteran population within the United States. 8. The influence of culture medium on the observed frequency of resistance.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1971 May; 103(5):722-4. PubMed ID: 4996270
    [No Abstract]   [Full Text] [Related]  

  • 32. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug resistance of Mycobacterium tuberculosis in Chandigarh.
    Mahajan RC; Agarwal SC
    Indian J Med Res; 1968 Aug; 56(8):1180-7. PubMed ID: 4179833
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance.
    Zykov MP; Donets JI; Poti SJ
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):40-56. PubMed ID: 4113512
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of drug resistance of M. tuberculosis strains using three different culture media.
    Montalbine V; Collins FM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):260-2. PubMed ID: 4101361
    [No Abstract]   [Full Text] [Related]  

  • 37. The attenuated W-115 strain of M. tuberculosis hominis and its isoniazid-resistant variant.
    Weissfeiler J; Karasseva V
    Am Rev Respir Dis; 1965 Dec; 92(6):870-6. PubMed ID: 4954268
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental studies on the isonicotinic acid hypothesis of the mechanism of action of isoniazid].
    Seydel JK; Wempe E; Nestler HJ
    Arzneimittelforschung; 1968 Mar; 18(3):362-7. PubMed ID: 4971942
    [No Abstract]   [Full Text] [Related]  

  • 39. A review of the action of isoniazid.
    Youatt J
    Am Rev Respir Dis; 1969 May; 99(5):729-49. PubMed ID: 4306211
    [No Abstract]   [Full Text] [Related]  

  • 40. [Decrease of isoniazid-resistant Mycobacterium strains].
    Fodor T
    Orv Hetil; 1979 Feb; 120(8):448. PubMed ID: 106354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.